Felodipine Tablet, Film Coated
Product Images NDC 63629-2016

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Felodipine (NDC 63629-2016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (1 Formula)

Image Description (1 Formula)
Chemical structure of Felodipine displayed as a 2D molecular diagram, showing its aromatic rings, chlorine atoms, ethyl ester group, and methoxycarbonyl functional groups.*
FDA Label Image

Label (Lbl636292016)

Label (Lbl636292016)
Label for Felodipine Extended-Release Tablets, USP 10 mg oral film-coated tablets by Bryant Ranch Prepack. The label includes the NDC number 63629-2016-1, a red border around the strength 10 mg, and indicates package size of 500 tablets. It also features storage and handling instructions, barcode, and BRP Pharmaceuticals logo.*
FDA Label Image

Table 1 (Table 1)

Table 1 (Table 1)
A data table titled 'Mean Reductions in Blood Pressure (mmHg)' presents results from two studies showing the effects of different doses of Felodipine on systolic and diastolic blood pressure, mean trough response, and trough/peak ratios. Study 1 includes doses of 2.5 mg, 5 mg, and 10 mg measured over 8 weeks, while Study 2 reports data for 10 mg and 20 mg doses over 4 weeks. The table notes placebo response subtraction and patient count variations for certain measures.*
FDA Label Image

Table 2 (Table 2)

Table 2 (Table 2)
A data table showing the percent of patients experiencing adverse events in controlled trials of Felodipine extended-release tablets at different doses (Placebo, 2.5 mg, 5 mg, 10 mg). The table categorizes adverse events by body system (e.g., body as a whole, cardiovascular, digestive, nervous, respiratory, skin) and includes incidence percentages along with discontinuation rates in parentheses across different dosages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.